Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Biosens Bioelectron ; 151: 112000, 2020 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-31999595

RESUMO

Herein, a multifunctional dual-modal imaging probe is successfully developed to integrate the advantages of second near-infrared window (NIR-II, 1000-1700 nm) fluorescence imaging (FI) and photoacoustic imaging (PAI) with the ultimate goal of improving diseases diagnosis and management. Melanin-inspired polydopamine (PDA) polymer coated NaYF4:Yb3+,Er3+@NaYbF4@NaYF4:Nd3+ down conversion nanoparticles (DCNPs) is designed via water-in-oil microemulsion method, which comprises a DCNP core, acting as the NIR-II optical imaging agent, and a PDA shell, acting as the PA contrast agent. By taking the advantages of high spatial resolution and excellent temporal resolution, the dual-modal contrast agent is capable for high sensitivity real-time visualization of gastrointestinal tract, diagnosis of gastrointestinal peristalsis disorder and NIR-II FI-guided intestinal obstruction surgery. All of the above results demonstrate the great potential of DCNP@PDA NP as an efficient NIR-II/PAI dual-modal contrast agent for precision medicine.


Assuntos
Técnicas Biossensoriais , Nanopartículas Metálicas/química , Técnicas Fotoacústicas , Meios de Contraste/química , Diagnóstico , Fluorescência , Trato Gastrointestinal/virologia , Humanos , Indóis/química , Fototerapia , Polímeros/química
2.
Nat Microbiol ; 4(12): 2405-2415, 2019 12.
Artigo em Inglês | MEDLINE | ID: mdl-31527795

RESUMO

A blood meal is the primary route through which mosquitoes acquire an arbovirus infection. Blood components or their metabolites may regulate the susceptibility of mosquitoes to arboviruses. Here we report that serum iron in human blood influences dengue virus acquisition by mosquitoes. Dengue virus acquisition by Aedes aegypti was inversely correlated with the iron concentration in serum from human donors. In a mouse-mosquito acquisition model, iron supplementation reduced dengue virus prevalence and viral load, whereas neutralization of serum iron facilitated dengue virus infection in A. aegypti mosquitoes. Of note, mosquitoes feeding on iron-deficient (sideropenic) mice exhibited a higher prevalence of dengue virus. Reversal of the sideropenic status of hosts largely reduced dengue virus acquisition and infection by mosquitoes. Serum iron, rather than haem-bound iron, was utilized by the mosquito iron metabolism pathway to boost the activity of reactive oxygen species in the gut epithelium, subsequently inhibiting infection by dengue virus. On the basis of these results, a status of iron deficiency in the human population might contribute to the vectorial permissiveness to dengue virus, thereby facilitating its spread by mosquitoes.


Assuntos
Aedes/virologia , Vírus da Dengue/efeitos dos fármacos , Dengue/virologia , Ferro/sangue , Ferro/farmacologia , Mosquitos Vetores/virologia , Anemia Ferropriva , Animais , Chlorocebus aethiops , Modelos Animais de Doenças , Feminino , Trato Gastrointestinal/virologia , Humanos , Ferro/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Espécies Reativas de Oxigênio , Células Vero
3.
Br Poult Sci ; 59(4): 389-395, 2018 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-29768944

RESUMO

1. The effect of Zataria multiflora essential oil on replication rate of the H9N2 virus in target organs was determined by real-time PCR. One-day-old broiler chicks were randomly divided into six groups and were challenged with H9N2 influenza. Two groups received either 20 or 40 µl/kg body weight/day Zataria multiflora essential oils (ZM) seven days before the challenge while two other groups received the essential oil at the same dosage but after H9N2 challenge. One group received 4 mg/kg body weight/day of the anti-viral compound amantadine after challenge and the last group received no treatment and served as the control. 2. Groups that received the ZM, before or after H9N2 challenge, and the amantadine treated group showed reduced viral replication in the respiratory and gastrointestinal tracts compared to the control. Supplementation with ZM improved weight gain and FCR in broilers in comparison with the control. 3. The results showed that ZM had a positive effect on reducing viral replication in both the intestine and trachea of H9N2 influenza infected broiler chickens, that led to milder clinical symptoms and better performance.


Assuntos
Galinhas , Vírus da Influenza A Subtipo H9N2/efeitos dos fármacos , Lamiaceae/química , Óleos Voláteis/metabolismo , Replicação Viral/efeitos dos fármacos , Amantadina/farmacologia , Ração Animal/análise , Animais , Antivirais/farmacologia , Dieta/veterinária , Suplementos Nutricionais/análise , Relação Dose-Resposta a Droga , Trato Gastrointestinal/virologia , Vírus da Influenza A Subtipo H9N2/fisiologia , Influenza Aviária/tratamento farmacológico , Influenza Aviária/fisiopatologia , Influenza Aviária/virologia , Óleos Voláteis/administração & dosagem , Doenças das Aves Domésticas/tratamento farmacológico , Doenças das Aves Domésticas/fisiopatologia , Doenças das Aves Domésticas/virologia , Distribuição Aleatória , Sistema Respiratório/virologia , Replicação Viral/fisiologia
4.
J Neuroinflammation ; 15(1): 94, 2018 Mar 24.
Artigo em Inglês | MEDLINE | ID: mdl-29573741

RESUMO

BACKGROUND: Diarrhea is a severe complication in HIV-1-infected patients with Trans-activator of transcription (HIV-1 Tat) protein being recognized as a major underlying cause. Beside its direct enterotoxic effects, Tat protein has been recently shown to affect enteric glial cell (EGC) activity. EGCs regulate intestinal inflammatory responses by secreting pro-inflammatory molecules; nonetheless, they might also release immune-regulatory factors, as palmytoilethanolamide (PEA), which exerts anti-inflammatory effects by activating PPARα receptors. We aimed at clarifying whether EGCs are involved in HIV-1 Tat-induced diarrhea and if PEA exerts antidiarrheal activity. METHODS: Diarrhea was induced by intracolonic administration of HIV-1 Tat protein in rats at day 1. PEA alone or in the presence of peroxisome proliferator-activated receptor (PPAR) antagonists was given intraperitoneally from day 2 to day 7. S100B, iNOS, NF-kappaB, TLR4 and GFAP expression were evaluated in submucosal plexi, while S100B and NO levels were measured in EGC submucosal plexi lysates, respectively. To verify whether PEA effects were PPARα-mediated, PPARα-/- mice were also used. After 7 days from diarrhea induction, endogenous PEA levels were measured in submucosal plexi homogenates deriving from rats and PPARα-/- mice. RESULTS: HIV-1 Tat protein induced rapid onset diarrhea alongside with a significant activation of EGCs. Tat administration significantly increased all hallmarks of neuroinflammation by triggering TLR4 and NF-kappaB activation and S100B and iNOS expression. Endogenous PEA levels were increased following HIV-1 Tat exposure in both wildtype and knockout animals. In PPARα-/- mice, PEA displayed no effects. In wildtype rats, PEA, via PPARα-dependent mechanism, resulted in a significant antidiarrheal activity in parallel with marked reduction of EGC-sustained neuroinflammation. CONCLUSIONS: EGCs mediate HIV-1 Tat-induced diarrhea by sustaining the intestinal neuroinflammatory response. These effects are regulated by PEA through a selective PPARα-dependent mechanism. PEA might be considered as an adjuvant therapy in HIV-1-induced diarrhea.


Assuntos
Antivirais/uso terapêutico , Diarreia/induzido quimicamente , Diarreia/tratamento farmacológico , Etanolaminas/uso terapêutico , Neuroglia/efeitos dos fármacos , Ácidos Palmíticos/uso terapêutico , Produtos do Gene tat do Vírus da Imunodeficiência Humana/toxicidade , Amidas , Anestésicos Locais/uso terapêutico , Animais , Modelos Animais de Doenças , Etanolaminas/metabolismo , Trato Gastrointestinal/patologia , Trato Gastrointestinal/virologia , Regulação Viral da Expressão Gênica/efeitos dos fármacos , Lidocaína/uso terapêutico , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , NF-kappa B/metabolismo , PPAR alfa/deficiência , PPAR alfa/genética , Ácidos Palmíticos/metabolismo , Ratos , Ratos Wistar , Subunidade beta da Proteína Ligante de Cálcio S100/metabolismo
5.
mBio ; 8(3)2017 05 02.
Artigo em Inglês | MEDLINE | ID: mdl-28465428

RESUMO

Antiviral innate host defenses against acute viral infections include suppression of host protein synthesis to restrict viral protein production. Less is known about mechanisms by which viral pathogens subvert host antiviral innate responses for establishing their replication and dissemination. We investigated early innate defense against human immunodeficiency virus (HIV) infection and viral evasion by utilizing human CD4+ T cell cultures in vitro and a simian immunodeficiency virus (SIV) model of AIDS in vivo Our data showed that early host innate defense against the viral infection involves GCN2-ATF4 signaling-mediated suppression of global protein synthesis, which is exploited by the virus for supporting its own replication during early viral infection and dissemination in the gut mucosa. Suppression of protein synthesis and induction of protein kinase GCN2-ATF4 signaling were detected in the gut during acute SIV infection. These changes diminished during chronic viral infection. HIV replication induced by serum deprivation in CD4+ T cells was linked to the induction of ATF4 that was recruited to the HIV long terminal repeat (LTR) to promote viral transcription. Experimental inhibition of GCN2-ATF4 signaling either by a specific inhibitor or by amino acid supplementation suppressed the induction of HIV expression. Enhancing ATF4 expression through selenium administration resulted in reactivation of latent HIV in vitro as well as ex vivo in the primary CD4+ T cells isolated from patients receiving suppressive antiretroviral therapy (ART). In summary, HIV/SIV exploits the early host antiviral response through GCN2-ATF4 signaling by utilizing ATF4 for activating the viral LTR transcription to establish initial viral replication and is a potential target for HIV prevention and therapy.IMPORTANCE Understanding how HIV overcomes host antiviral innate defense response in order to establish infection and dissemination is critical for developing prevention and treatment strategies. Most investigations focused on the viral pathogenic mechanisms leading to immune dysfunction following robust viral infection and dissemination. Less is known about mechanisms that enable HIV to establish its presence despite rapid onset of host antiviral innate response. Our novel findings provide insights into the viral strategy that hijacks the host innate response of the suppression of protein biosynthesis to restrict the virus production. The virus leverages transcription factor ATF4 expression during the GCN2-ATF4 signaling response and utilizes it to activate viral transcription through the LTR to support viral transcription and production in both HIV and SIV infections. This unique viral strategy is exploiting the innate response and is distinct from the mechanisms of immune dysfunction after the critical mass of viral loads is generated.


Assuntos
Fator 4 Ativador da Transcrição/metabolismo , Linfócitos T CD4-Positivos/virologia , HIV-1/fisiologia , Interações Hospedeiro-Patógeno , Imunidade Inata , Proteínas Serina-Treonina Quinases/metabolismo , Replicação Viral , Fator 4 Ativador da Transcrição/genética , Animais , Linfócitos T CD4-Positivos/efeitos dos fármacos , Células Cultivadas , Modelos Animais de Doenças , Trato Gastrointestinal/virologia , Infecções por HIV/tratamento farmacológico , Infecções por HIV/imunologia , Infecções por HIV/virologia , HIV-1/imunologia , HIV-1/patogenicidade , Humanos , Evasão da Resposta Imune , Macaca mulatta , Proteínas Serina-Treonina Quinases/genética , Selênio/farmacologia , Transdução de Sinais , Síndrome de Imunodeficiência Adquirida dos Símios/imunologia , Síndrome de Imunodeficiência Adquirida dos Símios/virologia , Vírus da Imunodeficiência Símia , Carga Viral , Latência Viral
7.
Trends Microbiol ; 22(7): 399-405, 2014 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-24656964

RESUMO

The human gut contains approximately 10(15) bacteriophages (the 'phageome'), probably the richest concentration of biological entities on earth. Mining and exploiting these potential 'agents of change' is an attractive prospect. For many years, phages have been used to treat bacterial infections in humans and more recently have been approved to reduce pathogens in the food chain. Phages have also been studied as drug or vaccine delivery vectors to help treat and prevent diseases such as cancer and chronic neurodegenerative conditions. Individual phageomes vary depending on age and health, thus providing a useful biomarker of human health as well as suggesting potential interventions targeted at the gut microbiota.


Assuntos
Bacteriófagos/isolamento & purificação , Terapia Biológica/métodos , Microbiologia de Alimentos/métodos , Trato Gastrointestinal/virologia , Vacinas Virais/imunologia , Indústria Alimentícia/métodos , Humanos , Vacinas Virais/administração & dosagem , Vacinas Virais/genética
8.
Curr Opin Microbiol ; 16(4): 500-6, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23725668

RESUMO

In the reductionist era T-type coliphage research became one of the foundations for molecular biology. The technological progress in systems biology makes it now possible to study T-type phage-Escherichia coli interaction in the natural ecological niche, the gut of warm blooded animals. This development gives a second chance to phages as anti-microbial agents ('phage therapy'). Bacteria growing in biofilms are difficult to treat with antibiotics while many phages express naturally depolymerases which attack the polysaccharide matrix that enmesh bacteria in biofilms. Phages were already used successfully to reduce contamination levels with medical catheters and might likewise be of use against infections frequently forming bacterial biofilms.


Assuntos
Escherichia coli/virologia , Trato Gastrointestinal/microbiologia , Trato Gastrointestinal/virologia , Fagos T/fisiologia , Animais , Biofilmes , Terapia Biológica/métodos , Ecossistema , Escherichia coli/fisiologia , Infecções por Escherichia coli/terapia , Humanos , Fagos T/crescimento & desenvolvimento
9.
Dev Comp Immunol ; 41(3): 341-51, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23542704

RESUMO

Macrophages (MPh) and dendritic cells (DC) are members of the mononuclear phagocyte system. In chickens, markers to distinguish MPh from DC are lacking, but whether MPh and DC can be distinguished in humans and mice is under debate, despite the availability of numerous markers. Mucosal MPh and DC are strategically located to ingest foreign antigens, suggesting they can rapidly respond to invading pathogens. This review addresses our current understanding of DC and MPh function, the receptors expressed by MPh and DC involved in pathogen recognition, and the responses of DC and MPh against respiratory and intestinal pathogens in the chicken. Furthermore, potential opportunities are described to modulate MPh and DC responses to enhance disease resistance, highlighting modulation through nutraceuticals and vaccination.


Assuntos
Galinhas/imunologia , Células Dendríticas/imunologia , Trato Gastrointestinal/imunologia , Macrófagos/imunologia , Sistema Respiratório/imunologia , Animais , Coccidiose/imunologia , Coccidiose/prevenção & controle , Células Dendríticas/microbiologia , Células Dendríticas/parasitologia , Células Dendríticas/virologia , Suplementos Nutricionais/estatística & dados numéricos , Infecções por Escherichia coli/imunologia , Infecções por Escherichia coli/prevenção & controle , Trato Gastrointestinal/microbiologia , Trato Gastrointestinal/parasitologia , Trato Gastrointestinal/virologia , Imunidade Inata , Imunomodulação , Influenza Aviária/imunologia , Influenza Aviária/prevenção & controle , Receptores de Lipopolissacarídeos/genética , Receptores de Lipopolissacarídeos/imunologia , Macrófagos/microbiologia , Macrófagos/parasitologia , Macrófagos/virologia , Sistema Respiratório/microbiologia , Sistema Respiratório/parasitologia , Sistema Respiratório/virologia , Lectinas Semelhantes a Imunoglobulina de Ligação ao Ácido Siálico/genética , Lectinas Semelhantes a Imunoglobulina de Ligação ao Ácido Siálico/imunologia , Vacinação/estatística & dados numéricos
10.
Nat Rev Microbiol ; 10(9): 607-17, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22864264

RESUMO

Over the past decade, researchers have begun to characterize viral diversity using metagenomic methods. These studies have shown that viruses, the majority of which infect bacteria, are probably the most genetically diverse components of the biosphere. Here, we briefly review the incipient rise of a phage biology renaissance, which has been catalysed by advances in next-generation sequencing. We explore how work characterizing phage diversity and lifestyles in the human gut is changing our view of ourselves as supra-organisms. Finally, we discuss how a renewed appreciation of phage dynamics may yield new applications for phage therapies designed to manipulate the structure and functions of our gut microbiomes.


Assuntos
Bactérias/virologia , Bacteriófagos/classificação , Bacteriófagos/genética , Biodiversidade , Biota , Trato Gastrointestinal/virologia , Sequenciamento de Nucleotídeos em Larga Escala/métodos , Infecções Bacterianas/terapia , Bacteriófagos/isolamento & purificação , Produtos Biológicos/uso terapêutico , Terapias Complementares/métodos , Trato Gastrointestinal/microbiologia , Humanos
11.
Int J Food Microbiol ; 153(1-2): 237-40, 2012 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-22137684

RESUMO

Bovine intestines, bladders and oesophagus are used for the production of natural casings ("beef casings") as edible sausage containers. Derived from cattle experimentally infected with FMDV (initial dosage 10(4) TCID(50)/mL, strain A Iran 97), these beef casings were treated with sodium chloride (NaCl) or phosphate supplemented salt (P-salt). In addition, different in-vitro experiments using beef casings were done on a small scale with other FMDV strains (A Turkey 06, C-Oberbayern and O(1) Manisa) as "proof of principle". Based on the combined results of the in-vivo and in-vitro experiments, it can be concluded that the storage period of 30 days at 20 °C in NaCl is sufficiently effective to inactivate a possible contamination with FMDV in beef casings and that the usage of P-salt does not clearly enhance the inactivation of FMDV infectivity. Storage of salted beef casings at about 20 °C for 30 days is already part of the Standard Operating Procedures (included in HACCP) of the international casing industry and can therefore be considered as a protective measure for the international trade in natural casings.


Assuntos
Vírus da Febre Aftosa/efeitos dos fármacos , Trato Gastrointestinal/virologia , Fosfatos/farmacologia , Cloreto de Sódio/farmacologia , Bexiga Urinária/virologia , Inativação de Vírus/efeitos dos fármacos , Animais , Bovinos , Esôfago/virologia , Microbiologia de Alimentos , Armazenamento de Alimentos , Febre Aftosa/virologia , Vírus da Febre Aftosa/isolamento & purificação , Intestinos/virologia , Produtos da Carne/virologia
12.
Cell Mol Life Sci ; 62(5): 511-9, 2005 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15747058

RESUMO

Bacteriophages (phages) are omnipresent in our environment, and recent studies highlight their potential impact on the microbial world. Phages can also be present in mammalian organisms, including man (intestines, oral cavity, urine, sputum and serum). Data are available which suggest that those endogenous phages could play an important role in eliminating bacteria and regulating the body ecosystem. Furthermore, our most recent findings suggest that phages can exert immunosuppressive action in the gut, helping control local inflammatory and autoimmune reactions, and demonstrate anticancer activity. We hypothesize that phages could act in concert with the immune system in immunosurveillance against bacteria, viruses and cancer.


Assuntos
Infecções Bacterianas/terapia , Bacteriófagos/fisiologia , Trato Gastrointestinal/virologia , Antibacterianos/uso terapêutico , Infecções Bacterianas/virologia , Bacteriófagos/imunologia , Terapia Biológica/métodos , Colífagos/imunologia , Colífagos/fisiologia , Trato Gastrointestinal/microbiologia , Humanos , Sistema Imunitário/fisiologia , Fatores Imunológicos/fisiologia , Fatores Imunológicos/uso terapêutico , Lisogenia/imunologia , Lisogenia/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA